Clinical Trial: A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Melanoma
Study Type: OBSERVATIONAL
Official Title: Real-World Evaluation of Patient Characteristics, Treatment Patterns, Safety, and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab for Pediatric Melanoma
Brief Summary:
The purpose of this study is to describe real-world safety outcomes in children with melanoma who are treated with nivolumab alone or nivolumab in combination with ipilimumab for unresectable or metastatic melanoma, or treated with adjuvant nivolumab after resection of stage IIB-IV melanoma.Demographic and clinical characteristics, and treatment patterns, will also be described in this population.
Read more